Divi's Laboratories Limited's latest marketcap:
As of 07/08/2025, Divi's Laboratories Limited's market capitalization has reached $21.33 B. According to our data, Divi's Laboratories Limited is the 1013th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 21.33 B |
| Revenue (ttm) | 1.09 B |
| Net Income (ttm) | 255.51 M |
| Shares Out | 265.47 M |
| EPS (ttm) | 0.96 |
| Forward PE | 67.85 |
| Ex-Dividend Date | 07/25/2025 |
| Earnings Date | 08/07/2025 |
Divi's Laboratories Limited's yearly market capitalization.
| Date | Market Cap(₹) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/08/2025 | ₹1.83 T | $21.33 B | 12.95% | 1013 |
| 12/31/2024 | ₹1.62 T | $18.91 B | 56.22% | 992 |
| 12/29/2023 | ₹1.04 T | $12.46 B | 14.38% | 1347 |
| 12/30/2022 | ₹906.1 B | $10.95 B | -27.04% | 1412 |
| 12/31/2021 | ₹1.24 T | $16.67 B | 21.77% | 1181 |
| 12/31/2020 | ₹1.02 T | $13.95 B | 108.14% | 1202 |
| 12/31/2019 | ₹490 B | $6.86 B | 24.49% | 1847 |
| 12/31/2018 | ₹393.6 B | $5.66 B | 34.99% | 1820 |
| 12/29/2017 | ₹291.58 B | $4.57 B | 40.15% | 2510 |
| 12/30/2016 | ₹208.05 B | $3.06 B | -32.14% | 2866 |
Company Profile
About Divi's Laboratories Limited
Divi's Laboratories Limited is a leading manufacturer and supplier of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals. The company operates in India, North America, Asia, Europe, and other international markets.
Products & Services
- Manufacturing and sale of APIs and intermediates
- Custom synthesis and contract manufacturing services for APIs and intermediates
- Nutraceuticals, including carotenoids such as beta carotene, astaxanthin, lycopene, and canthaxanthin
- Finished forms like lutein and vitamins for food, dietary supplements, and feed industries
Global Presence
The company exports its products worldwide, serving diverse industries with high-quality pharmaceutical and nutraceutical solutions.
Company Background
Originally established as Divi's Research Center in 1990, the company was renamed Divi's Laboratories Limited in 1994. Headquartered in Hyderabad, India, it has grown into a key player in the pharmaceutical and nutraceutical sectors.
Frequently Asked Questions
-
What is Divi's Laboratories Limited's (NSE-DIVISLAB) current market cap?As of 07/08/2025, Divi's Laboratories Limited (including the parent company, if applicable) has an estimated market capitalization of $21.33 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Divi's Laboratories Limited (NSE-DIVISLAB) rank globally by market cap?Divi's Laboratories Limited global market capitalization ranking is approximately 1013 as of 07/08/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.